BIGG

Guidelines on the Management of Latent Tuberculosis Infection

World Health Organization.

The overall objective of the guidelines is to provide public health approach guidance on evidencebased practices for testing, treating and managing LTBI in individuals with the highest risk of progression to active disease. The guidelines are expected to provide the basis and rationale for the developmen...

Antituberculosos/administración & dosificación, Tuberculosis Latente/tratamiento farmacológico, Tuberculosis Latente/prevención & control, Poblaciones Vulnerables, Resultado del Tratamiento, Cumplimiento de la Medicación, Rifampin/administración & dosificación, Isoniazida/administración & dosificación, Quimioterapia Combinada, Tuberculosis Latente/diagnóstico

Texto completo (enlace principal) Texto completo (enlace alternativo) Texto completo (enlace alternativo)

Recommendation on 36 months isoniazid preventive therapy to adults and adolescents living with HIV in resource-constrained and high TB and HIV-prevalence settings: 2015 update

In 2011 WHO conditionally recommended the use of at least 36 months of isoniazid preventive therapy (IPT) (as a proxy for lifelong or continuous treatment) for people living with HIV in high TB-prevalence and transmission settings. The evidence of the benefits and harms of 36-month IPT compared to 6-mont...